The failure of current strategies to provide an explanation for controversial findings on the pattern of pathophysiological changes in Alzheimer’s Disease (AD) motivates the necessity to develop new integrative approaches based on multi-modal neuroimaging data that captures various aspects of disease pathology. Previous studies using [18F]fluorodeoxyglucose positron emission tomography (FDG-PET) and structural magnetic resonance imaging (sMRI) report controversial results about time-line, spatial extent and magnitude of glucose hypometabolism and atrophy in AD that depend on clinical and demographic characteristics of the studied populations. Here, we provide and validate at a group level a generative anatomical model of glucose hypo-metabo...
Gray matter (GM) atrophy and brain glucose hypometabolism are already detected in the predementia st...
Simultaneously evaluating resting-state brain glucose metabolism and intrinsic functional activity h...
International audienceAlzheimer's disease (AD), the most common age-related neurodegenerative disord...
The failure of current strategies to provide an explanation for controversial findings on the patter...
The failure of current strategies to provide an explanation for controversial findings on the patter...
The failure of current strategies to provide an explanation for controversial findings on the patter...
The early diagnostic value of glucose hypometabolism and atrophy as potential neuroimaging biomarker...
AbstractThe early diagnostic value of glucose hypometabolism and atrophy as potential neuroimaging b...
International audienceGray matter atrophy, glucose hypometabolism, and β-amyloid Aβ deposition are w...
F FDG-PET) has gained a leading role in the diagnostic assessment of patients with cognitive complai...
Abstract Several neuroimaging techniques are promising tools as early markers of brain pathology in ...
Posterior cortical hypometabolism measured with [ 18 F]-Fluorodeoxyglucose (FDG)-PET is a well-known...
The early diagnostic value of glucose hypometabolism and atrophy as potential neuroimaging biomarker...
Current Positron Emission Tomography (PET) biomarkers for Alzheimer’s disease (AD) assess either neu...
The etiology of Alzheimer’s disease involves the presymptomatic development and progression of amylo...
Gray matter (GM) atrophy and brain glucose hypometabolism are already detected in the predementia st...
Simultaneously evaluating resting-state brain glucose metabolism and intrinsic functional activity h...
International audienceAlzheimer's disease (AD), the most common age-related neurodegenerative disord...
The failure of current strategies to provide an explanation for controversial findings on the patter...
The failure of current strategies to provide an explanation for controversial findings on the patter...
The failure of current strategies to provide an explanation for controversial findings on the patter...
The early diagnostic value of glucose hypometabolism and atrophy as potential neuroimaging biomarker...
AbstractThe early diagnostic value of glucose hypometabolism and atrophy as potential neuroimaging b...
International audienceGray matter atrophy, glucose hypometabolism, and β-amyloid Aβ deposition are w...
F FDG-PET) has gained a leading role in the diagnostic assessment of patients with cognitive complai...
Abstract Several neuroimaging techniques are promising tools as early markers of brain pathology in ...
Posterior cortical hypometabolism measured with [ 18 F]-Fluorodeoxyglucose (FDG)-PET is a well-known...
The early diagnostic value of glucose hypometabolism and atrophy as potential neuroimaging biomarker...
Current Positron Emission Tomography (PET) biomarkers for Alzheimer’s disease (AD) assess either neu...
The etiology of Alzheimer’s disease involves the presymptomatic development and progression of amylo...
Gray matter (GM) atrophy and brain glucose hypometabolism are already detected in the predementia st...
Simultaneously evaluating resting-state brain glucose metabolism and intrinsic functional activity h...
International audienceAlzheimer's disease (AD), the most common age-related neurodegenerative disord...